Villers-lès-Nancy (France), 31 July 2025 - 6:00 PM (CET) PRESS RELEASE | H1 2025 Group | 2024 Reported | 2025 Reported | Change / | | Of which external | Like-for-like change | | | --- | --- | --- | --- | --- | --- | --- | --- | | revenue (€m) | | | Reported basis | | | (organic growth) | | | | basis | basis | | | growth | | | | Q1 | 53.3 | 57.0 | 3.7 | 6.9% | 0.5 | 3.2 | 5.9% | | Q2 | 54.7 | 58.9 | 4.3 | 7.8% | 0.5 | 3.8 | 6.9% | | Total | 108.0 | 116.0 | 8.0 | 7.4% | 1.1 | 6.9 | 6.4% | H1 revenue at 30 Ju ...

Hims & Hers Health (NYSE: HIMS) experienced a notable uptick in its stock price following the announcement of its planned acquisition of ZAVA, a prominent European digital health platform. The stock rose 7.77% in pre-market trading on June 3, 2025, reflecting investor optimism about the company’s strategic expansion into Europe. HIMS shares closed at $56.77 on Monday, reflecting a year-to-date increase of approximately 134.78% and a 39.07% gain over the past month. HIMS stock climbs over 7% in pre-market. S ...